Search Reports
Categories
Categories

Global Antiserum Market

Global Antiserum Market Research Report 2024(Status and Outlook)

Report Code : PHA1889
Published Date : 05 December, 2024 | No of Pages: 159

  • Report Description
  • Table of Contents
  • Companies Mentioned
  • Related Reports


Report Overview
Antiserum, a vital component in the field of immunology and healthcare, plays a crucial role in treating various infectious diseases and venomous bites. It is a blood product that contains antibodies against specific antigens and is used to provide passive immunity. The market for antiserum is characterized by its essential role in managing medical emergencies, particularly in cases of snakebites, rabies, and certain types of poisoning.

As of 2023, the global antiserum market is valued at approximately USD 700 million. The market is projected to grow at a Compound Annual Growth Rate (CAGR) of 5.80% from 2024 to 2032. Key growth drivers for the antiserum market include the increasing incidence of snakebites and infectious diseases globally, rising awareness about the importance of antiserum in emergency medical care, and advancements in biotechnology leading to the development of more effective antiserum products.

One of the prominent trends in the antiserum market is the growing demand for region-specific antivenoms tailored to treat bites from local snake species. For example, in regions like sub-Saharan Africa and South Asia, where snakebite incidents are prevalent, there is a rising trend towards developing antivenoms specific to the venom composition of local snake species. This trend is driven by the need for more targeted and effective treatments for snakebites.

Another trend shaping the antiserum market is the increasing adoption of recombinant DNA technology in antiserum production. This technology allows for the production of monoclonal antibodies with high specificity and reduced side effects compared to traditional antiserum derived from animal sources. The trend towards using recombinant DNA technology is driven by the growing demand for safer and more efficient antiserum products.

In terms of regional market distribution, regions with high incidences of snakebites such as South Asia, sub-Saharan Africa, and parts of Latin America are the leading markets for antiserum. The dominance of these regions is primarily due to the prevalence of venomous snakes and the urgent need for effective antivenom treatments. Market dynamics in these regions are influenced by factors such as government initiatives to improve access to antiserum in rural areas, partnerships between healthcare organizations and pharmaceutical companies to enhance antiserum production, and ongoing research and development efforts to create more potent antiserum formulations.

Despite the significant growth prospects, the antiserum market faces challenges such as limited access to antiserum in remote regions, variations in regulatory standards for antiserum production across different countries, and the high cost associated with developing and manufacturing antivenom products. Addressing these challenges will require collaborative efforts from governments, healthcare organizations, and pharmaceutical companies to ensure the availability of affordable and high-quality antiserum products in regions that need them the most.
This report provides a deep insight into the global Antiserum market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Antiserum Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Antiserum market in any manner.
Global Antiserum Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
BD
Bio-Rad
Shanghai Serum Bio-Technology Co.
Ltd.
China National Pharmaceutical Group
CSL
Merck
BTG
Pfizer
Haffkine Bio-Pharmaceutical
Vins Bioproducts
Bharat Serums and Vaccines
SSI Diagnostica
GD Animal Health
MicroPharm
Peptide Institute Inc.
Rare Disease Therapeutics

Market Segmentation (by Type)
Antitoxin Serum
Antibacterial Serum
Antiviral Serum
Others

Market Segmentation (by Application)
Clinical
Laboratory

Geographic Segmentation
• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:
• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Antiserum Market
• Overview of the regional outlook of the Antiserum Market:

Key Reasons to Buy this Report:
• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Antiserum Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market\'s competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter\'s five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

  Table of Contents
  1 Research Methodology and Statistical Scope
      1.1 Market Definition and Statistical Scope of Antiserum
      1.2 Key Market Segments
            1.2.1 Antiserum Segment by Type
            1.2.2 Antiserum Segment by Application
      1.3 Methodology & Sources of Information
            1.3.1 Research Methodology
            1.3.2 Research Process
            1.3.3 Market Breakdown and Data Triangulation
            1.3.4 Base Year
            1.3.5 Report Assumptions & Caveats
  2 Antiserum Market Overview
      2.1 Global Market Overview
            2.1.1 Global Antiserum Market Size (M USD) Estimates and Forecasts (2019-2032)
            2.1.2 Global Antiserum Sales Estimates and Forecasts (2019-2032)
      2.2 Market Segment Executive Summary
      2.3 Global Market Size by Region
      2.4 Macroeconomic Analysis
  3 Antiserum Market Competitive Landscape
      3.1 Global Antiserum Sales by Manufacturers (2019-2024)
      3.2 Global Antiserum Revenue Market Share by Manufacturers (2019-2024)
      3.3 Antiserum Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
      3.4 Global Antiserum Average Price by Manufacturers (2019-2024)
      3.5 Manufacturers Antiserum Sales Sites, Area Served, Product Type
      3.6 Antiserum Market Competitive Situation and Trends
            3.6.1 Antiserum Market Concentration Rate
            3.6.2 Global 5 and 10 Largest Antiserum Players Market Share by Revenue
            3.6.3 Mergers & Acquisitions, Expansion
  4 Antiserum Industry Chain Analysis
      4.1 Antiserum Industry Chain Analysis
      4.2 Market Overview of Key Raw Materials
      4.3 Midstream Market Analysis
      4.4 Downstream Customer Analysis
  5 The Development and Dynamics of Antiserum Market
      5.1 Key Development Trends
      5.2 Driving Factors
      5.3 Market Challenges
      5.4 Market Restraints
      5.5 Industry News
            5.5.1 New Product Developments
            5.5.2 Mergers & Acquisitions
            5.5.3 Expansions
            5.5.4 Collaboration/Supply Contracts
      5.6 Industry Policies
  6 Antiserum Market Segmentation by Type
      6.1 Evaluation Matrix of Segment Market Development Potential (Type)
      6.2 Global Antiserum Sales Market Share by Type (2019-2024)
      6.3 Global Antiserum Market Size Market Share by Type (2019-2024)
      6.4 Global Antiserum Price by Type (2019-2024)
  7 Antiserum Market Segmentation by Application
      7.1 Evaluation Matrix of Segment Market Development Potential (Application)
      7.2 Global Antiserum Market Sales by Application (2019-2024)
      7.3 Global Antiserum Market Size (M USD) by Application (2019-2024)
      7.4 Global Antiserum Sales Growth Rate by Application (2019-2024)
  8 Antiserum Market Sales by Region
      8.1 Global Antiserum Sales by Region
            8.1.1 Global Antiserum Sales by Region
            8.1.2 Global Antiserum Sales Market Share by Region
      8.2 Global Antiserum Market Size by Region
            8.2.1 Global Antiserum Market Size by Region
            8.2.2 Global Antiserum Market Size Market Share by Region
      8.3 North America
            8.3.1 North America Antiserum Sales by Country
            8.3.2 North America Antiserum Market Size by Country
            8.3.3 U.S. Market Overview
            8.3.4 Canada Market Overview
            8.3.5 Mexico Market Overview
      8.4 Europe
            8.4.1 Europe Antiserum Sales by Country
            8.4.2 Europe Antiserum Market Size by Country
            8.4.3 Germany Market Overview
            8.4.4 France Market Overview
            8.4.5 U.K. Market Overview
            8.4.6 Italy Market Overview
            8.4.7 Russia Market Overview
      8.5 Asia Pacific
            8.5.1 Asia Pacific Antiserum Sales by Region
            8.5.2 China
            8.5.3 Japan
            8.5.4 South Korea
            8.5.5 India
            8.5.6 Southeast Asia
      8.6 Asia Pacific
            8.6.1 Asia Pacific Antiserum Market Size by Region
            8.6.2 Asia Pacific Antiserum Market Size by Region
            8.6.3 China
            8.6.4 Japan
            8.6.5 South Korea
            8.6.6 India
            8.6.7 Southeast Asia
      8.7 South America
            8.7.1 South America Antiserum Sales by Country
            8.7.2 South America Antiserum Market Size by Country
            8.7.3 Brazil
            8.7.4 Argentina
            8.7.5 Columbia
      8.8 Middle East and Africa
            8.8.1 Middle East and Africa Antiserum Sales by Region
            8.8.2 Middle East and Africa Antiserum Market Size by Region
            8.8.3 Saudi Arabia
            8.8.4 UAE
            8.8.5 Egypt
            8.8.6 Nigeria
            8.8.7 South Africa
  9 Antiserum Market Production by Region
      9.1 Global Production of Antiserum by Region (2019-2024)
      9.2 Global Antiserum Revenue Market Share by Region (2019-2024)
      9.3 Global Antiserum Production, Revenue, Price and Gross Margin (2019-2024)
      9.4 North America Antiserum Production
            9.4.1 North America Antiserum Production Growth Rate (2019-2024)
            9.4.2 North America Antiserum Production, Revenue, Price and Gross Margin (2019-2024)
      9.5 Europe Antiserum Production
            9.5.1 Europe Antiserum Production Growth Rate (2019-2024)
            9.5.2 Europe Antiserum Production, Revenue, Price and Gross Margin (2019-2024)
      9.6 Japan Antiserum Production (2019-2024)
            9.6.1 Japan Antiserum Production Growth Rate (2019-2024)
            9.6.2 Japan Antiserum Production, Revenue, Price and Gross Margin (2019-2024)
      9.7 China Antiserum Production (2019-2024)
            9.7.1 China Antiserum Production Growth Rate (2019-2024)
            9.7.2 China Antiserum Production, Revenue, Price and Gross Margin (2019-2024)
  10 Key Companies Profile
      10.1 BD
            10.1.1 BD Antiserum Basic Information
            10.1.2 BD Antiserum Product Overview
            10.1.3 BD Antiserum Product Market Performance
            10.1.4 BD Business Overview
            10.1.5 BD Antiserum SWOT Analysis
            10.1.6 BD Recent Developments
      10.2 Bio-Rad
            10.2.1 Bio-Rad Antiserum Basic Information
            10.2.2 Bio-Rad Antiserum Product Overview
            10.2.3 Bio-Rad Antiserum Product Market Performance
            10.2.4 Bio-Rad Business Overview
            10.2.5 Bio-Rad Antiserum SWOT Analysis
            10.2.6 Bio-Rad Recent Developments
      10.3 Shanghai Serum Bio-Technology Co.
            10.3.1 Shanghai Serum Bio-Technology Co. Antiserum Basic Information
            10.3.2 Shanghai Serum Bio-Technology Co. Antiserum Product Overview
            10.3.3 Shanghai Serum Bio-Technology Co. Antiserum Product Market Performance
            10.3.4 Shanghai Serum Bio-Technology Co. Antiserum SWOT Analysis
            10.3.5 Shanghai Serum Bio-Technology Co. Business Overview
            10.3.6 Shanghai Serum Bio-Technology Co. Recent Developments
      10.4 Ltd.
            10.4.1 Ltd. Antiserum Basic Information
            10.4.2 Ltd. Antiserum Product Overview
            10.4.3 Ltd. Antiserum Product Market Performance
            10.4.4 Ltd. Business Overview
            10.4.5 Ltd. Recent Developments
      10.5 China National Pharmaceutical Group
            10.5.1 China National Pharmaceutical Group Antiserum Basic Information
            10.5.2 China National Pharmaceutical Group Antiserum Product Overview
            10.5.3 China National Pharmaceutical Group Antiserum Product Market Performance
            10.5.4 China National Pharmaceutical Group Business Overview
            10.5.5 China National Pharmaceutical Group Recent Developments
      10.6 CSL
            10.6.1 CSL Antiserum Basic Information
            10.6.2 CSL Antiserum Product Overview
            10.6.3 CSL Antiserum Product Market Performance
            10.6.4 CSL Business Overview
            10.6.5 CSL Recent Developments
      10.7 Merck
            10.7.1 Merck Antiserum Basic Information
            10.7.2 Merck Antiserum Product Overview
            10.7.3 Merck Antiserum Product Market Performance
            10.7.4 Merck Business Overview
            10.7.5 Merck Recent Developments
      10.8 BTG
            10.8.1 BTG Antiserum Basic Information
            10.8.2 BTG Antiserum Product Overview
            10.8.3 BTG Antiserum Product Market Performance
            10.8.4 BTG Business Overview
            10.8.5 BTG Recent Developments
      10.9 Pfizer
            10.9.1 Pfizer Antiserum Basic Information
            10.9.2 Pfizer Antiserum Product Overview
            10.9.3 Pfizer Antiserum Product Market Performance
            10.9.4 Pfizer Business Overview
            10.9.5 Pfizer Recent Developments
      10.10 Haffkine Bio-Pharmaceutical
            10.10.1 Haffkine Bio-Pharmaceutical Antiserum Basic Information
            10.10.2 Haffkine Bio-Pharmaceutical Antiserum Product Overview
            10.10.3 Haffkine Bio-Pharmaceutical Antiserum Product Market Performance
            10.10.4 Haffkine Bio-Pharmaceutical Business Overview
            10.10.5 Haffkine Bio-Pharmaceutical Recent Developments
      10.11 Vins Bioproducts
            10.11.1 Vins Bioproducts Antiserum Basic Information
            10.11.2 Vins Bioproducts Antiserum Product Overview
            10.11.3 Vins Bioproducts Antiserum Product Market Performance
            10.11.4 Vins Bioproducts Business Overview
            10.11.5 Vins Bioproducts Recent Developments
      10.12 Bharat Serums and Vaccines
            10.12.1 Bharat Serums and Vaccines Antiserum Basic Information
            10.12.2 Bharat Serums and Vaccines Antiserum Product Overview
            10.12.3 Bharat Serums and Vaccines Antiserum Product Market Performance
            10.12.4 Bharat Serums and Vaccines Business Overview
            10.12.5 Bharat Serums and Vaccines Recent Developments
      10.13 SSI Diagnostica
            10.13.1 SSI Diagnostica Antiserum Basic Information
            10.13.2 SSI Diagnostica Antiserum Product Overview
            10.13.3 SSI Diagnostica Antiserum Product Market Performance
            10.13.4 SSI Diagnostica Business Overview
            10.13.5 SSI Diagnostica Recent Developments
      10.14 GD Animal Health
            10.14.1 GD Animal Health Antiserum Basic Information
            10.14.2 GD Animal Health Antiserum Product Overview
            10.14.3 GD Animal Health Antiserum Product Market Performance
            10.14.4 GD Animal Health Business Overview
            10.14.5 GD Animal Health Recent Developments
      10.15 MicroPharm
            10.15.1 MicroPharm Antiserum Basic Information
            10.15.2 MicroPharm Antiserum Product Overview
            10.15.3 MicroPharm Antiserum Product Market Performance
            10.15.4 MicroPharm Business Overview
            10.15.5 MicroPharm Recent Developments
      10.16 Peptide Institute Inc.
            10.16.1 Peptide Institute Inc. Antiserum Basic Information
            10.16.2 Peptide Institute Inc. Antiserum Product Overview
            10.16.3 Peptide Institute Inc. Antiserum Product Market Performance
            10.16.4 Peptide Institute Inc. Business Overview
            10.16.5 Peptide Institute Inc. Recent Developments
      10.17 Rare Disease Therapeutics
            10.17.1 Rare Disease Therapeutics Antiserum Basic Information
            10.17.2 Rare Disease Therapeutics Antiserum Product Overview
            10.17.3 Rare Disease Therapeutics Antiserum Product Market Performance
            10.17.4 Rare Disease Therapeutics Business Overview
            10.17.5 Rare Disease Therapeutics Recent Developments
  11 Antiserum Market Forecast by Region
      11.1 Global Antiserum Market Size Forecast
      11.2 Global Antiserum Market Forecast by Region
            11.2.1 North America Market Size Forecast by Country
            11.2.2 Europe Antiserum Market Size Forecast by Country
            11.2.3 Asia Pacific Antiserum Market Size Forecast by Region
            11.2.4 South America Antiserum Market Size Forecast by Country
            11.2.5 Middle East and Africa Forecasted Sales of Antiserum by Country
  12 Forecast Market by Type and by Application (2025-2032)
      12.1 Global Antiserum Market Forecast by Type (2025-2032)
            12.1.1 Global Forecasted Sales of Antiserum by Type (2025-2032)
            12.1.2 Global Antiserum Market Size Forecast by Type (2025-2032)
            12.1.3 Global Forecasted Price of Antiserum by Type (2025-2032)
      12.2 Global Antiserum Market Forecast by Application (2025-2032)
            12.2.1 Global Antiserum Sales (K MT) Forecast by Application
            12.2.2 Global Antiserum Market Size (M USD) Forecast by Application (2025-2032)
  13 Conclusion and Key Findings
BD
Bio-Rad
Shanghai Serum Bio-Technology Co.
Ltd.
China National Pharmaceutical Group
CSL
Merck
BTG
Pfizer
Haffkine Bio-Pharmaceutical
Vins Bioproducts
Bharat Serums and Vaccines
SSI Diagnostica
GD Animal Health
MicroPharm
Peptide Institute Inc.
Rare Disease Therapeutics
Please select License
Single User Price:$ 2800
Site License Price:$ 3600
Enterprise Price:$ 3600